These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 3295597)
1. [Therapy of the hepatorenal syndrome]. Laffi G; Gentilini P Minerva Med; 1987 May; 78(10):669-74. PubMed ID: 3295597 [No Abstract] [Full Text] [Related]
2. Pathogenesis and management of the hepatorenal syndrome. Laffi G; La Villa G; Gentilini P Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664 [No Abstract] [Full Text] [Related]
3. [Physiopathology of refractory ascites and the hepatorenal syndrome]. Arroyo V Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916 [No Abstract] [Full Text] [Related]
4. Hepatorenal syndrome: definition, pathophysiology, clinical features and management. Bataller R; Sort P; Ginès P; Arroyo V Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573 [No Abstract] [Full Text] [Related]
5. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. Arroyo V; Terra C; Ginès P J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801 [No Abstract] [Full Text] [Related]
6. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment]. Torre A; Terra C; Guevara M; Ginès P Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529 [No Abstract] [Full Text] [Related]
7. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Wong F; Pantea L; Sniderman K Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086 [TBL] [Abstract][Full Text] [Related]
13. The hepatorenal syndrome. Punukollu RC; Gopalswamy N Med Clin North Am; 1990 Jul; 74(4):933-43. PubMed ID: 2195263 [TBL] [Abstract][Full Text] [Related]
14. Hepatorenal syndrome: pathophysiology and management. Wadei HM; Mai ML; Ahsan N; Gonwa TA Clin J Am Soc Nephrol; 2006 Sep; 1(5):1066-79. PubMed ID: 17699328 [No Abstract] [Full Text] [Related]
15. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls]. Kreuzer W Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345 [TBL] [Abstract][Full Text] [Related]
16. Hepato-renal syndrome: pathogenesis and management. Anand AC Trop Gastroenterol; 1995; 16(2):74-91. PubMed ID: 8644368 [No Abstract] [Full Text] [Related]